Literature DB >> 30927589

Synthesis and biological evaluation of new bisindole-imidazopyridine hybrids as apoptosis inducers.

Satish Sunkari1, Srinivasa Reddy Bonam2, A V Subba Rao3, Sd Riyaz4, V Lakshma Nayak3, Halmuthur Mahabalarao Sampath Kumar2, Ahmed Kamal5, Bathini Nagendra Babu6.   

Abstract

A series of diindolylmethanes (5a-t) were designed, synthesized, and examined for their cytotoxicity against four human cancer cell lines like prostate (DU-145), lung (A549), breast (MCF-7) and cervical cancer (HeLa). These results revealed that among all the hybrids, two (5k and 5r) were identified and exhibited significant cytotoxic effect against A549 cancer cells with IC50 values of 1.65 ± 0.3 and 1.80 ± 0.8 µM respectively. To investigate the reasons for the cytotoxic activity, the conventional biological assays were carried out with 5k and 5r on the A549 cancer cells. Both hybrids led to the arrest of A549 cell lines at the G2/M phase of the cell cycle and strongly induced apoptosis. Further the apoptotic effects of 5k and 5r were confirmed by ROS, annexin-V FITC, and mitochondrial membrane potential. Moreover, structure-activity relationships were elucidated with various substitutions on these hybrids.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Bisindole-imidazopyridine; Cytotoxicity; Heterocyclic; ROS

Year:  2019        PMID: 30927589     DOI: 10.1016/j.bioorg.2019.03.061

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  2 in total

1.  New imidazo[2,1-b]thiazole-based aryl hydrazones: unravelling their synthesis and antiproliferative and apoptosis-inducing potential.

Authors:  Mohd Adil Shareef; Ganthala Parimala Devi; Sunitha Rani Routhu; C Ganesh Kumar; Ahmed Kamal; Bathini Nagendra Babu
Journal:  RSC Med Chem       Date:  2020-07-22

2.  A Novel Imidazopyridine Derivative Exerts Anticancer Activity by Inducing Mitochondrial Pathway-Mediated Apoptosis.

Authors:  Juanli Wang; Hong Wu; Guiting Song; Donglin Yang; Jiuhong Huang; Xiaofang Yao; Hongxia Qin; ZhongZhu Chen; Zhigang Xu; Chuan Xu
Journal:  Biomed Res Int       Date:  2020-08-25       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.